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abstract
PURPOSE Patients with breast cancer in Pakistan commonly present with advanced disease. The objectives of
this study were to evaluate the frequency and length of delays in seeking medical consultation and to assess the
factors associated with them.
METHODS Four hundred ninety-nine patients with newly diagnosed breast cancer were enrolled and interviewed
over the period from February 2015 to August 2017. Information on sociodemographic factors, delay to medical
consultation, stage of breast cancer at presentation, and tumor characteristics of the breast cancer were
collected through face-to-face interviews and medical file review.
RESULTS The mean (standard deviation) age of patients with breast cancer was 48.0 (12.3) years. The mean
(standard deviation) patient delay was 15.7 (25.9) months, with 55.2% of women detecting a breast lump but
not seeking a medical consultation because of a lack of awareness about the significance of the lump. A total of
9.4% of the women decided to seek treatment initially using complementary and alternative medicine and
traditional treatment; 9.4% of the women presented to a health care provider with a breast lump but no action
was taken, and they were wrongly reassured about the lump without mammography or biopsy. For 26% of the
women, the delay in presentation was caused by anxiety, fears and misconceptions regarding diagnosis and
treatment, and other social factors including possible adverse effects on their relationship with their husband.
Multivariable analysis showed a strong association of lower socioeconomic status (odds ratio [OR], 8.11
[95% CI, 2.46 to 26.69]) and late stage of breast cancer (OR, 4.83 [95% CI, 1.74 to 13.39]) with a patient delay
of ≥ 3 months.
CONCLUSION Patient delay is a serious problem in Pakistan. There is an urgent need for intensive and com-
prehensive breast cancer education that addresses the myths and misconceptions related to breast cancer.
JCO Global Oncol 6:873-883. © 2020 by American Society of Clinical Oncology
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INTRODUCTION
Although breast cancer incidence was reported ini-
tially to be highest in developed countries, its in-
cidence is rising rapidly in lower- and middle-income
countries (LMICs) such as Pakistan.1,2 The incidence
of breast cancer among females in Pakistan has been
shown previously to be 2.5 times greater than that in
India or Iran.3 Pakistan is a developing country and
is in the lower- and middle-income category with
countries such as Bangladesh, Bhutan, and India,
where in 2017 gross national income per capita was
US $5,830 and total expenditure on health as a per-
centage of GDP was only 2.6%.4 According to a study
undertaken at Aga Khan University Hospital (AKUH),
the financial burden of cancer care is huge and
overwhelming.5 Pakistan is the fifth most populous
country in the world, and Karachi, the most populous
city in Pakistan, has an estimated population of 24
million, which includes people from multiple eth-
nicities. However, there is a dearth of well-equipped
cancer hospitals: nearly 320,000 new cases of
cancer are expected every year in Pakistan, but the
entire country has only 20 cancer hospitals. More-
over, there are no palliative care facilities or hospices
for patients with advanced cancer.6 Pakistan to this
day does not have any national breast cancer
screening or awareness programs, and this is likely to
contribute to presentation of the disease at a more
advanced stage.7
Early detection of breast cancer is of critical impor-
tance because smaller tumor sizes and reduced
chances of metastasis are major factors in overall
better survival.8 A delay in detection of breast cancer
is associated with larger tumor size, increased risk of
involvement of lymph nodes and distant metastasis,
and subsequent poor survival after surgery. Earlier
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diagnosis may be possible with self-screening and a better
awareness and understanding of the early signs of breast
cancer. A Thai study found that patients delayed seeking
a medical diagnosis even when there were physical signs
of breast cancer.9 Patients with breast cancer in Pakistan
commonly present with advanced disease, and this re-
mains a dilemma for the treating oncologists and sur-
geons. According to a local study in Pakistan, 69.9% of
patients with breast cancer had stage III or IV disease at
the time of first presentation.10 Previous studies have also
shown high rates of delay in breast cancer diagnosis,
with 39% reporting late in northern Pakistan and going
for their first visit regarding the breast lump after a delay
of 6 months after noting any symptoms.11-13 The delay
in presentation and detection of patients with breast
cancer is a major contributor to the advanced stage at
presentation and to the increased mortality rates in
Pakistan.12 Development of specific strategies by poli-
cymakers to reduce delays requires an understanding of
the factors that influence this delay.14,15 Strategies could
include public education and awareness campaigns
about the symptoms and signs of breast cancer, breast
self-examination (BSE), and screening mammography,
and encouraging women to seek medical consultation at
the earliest possible time.16 Delayed presentation of
cancer has a significant economic impact because it is
far less expensive to treat patients with early-stage dis-
ease and success rates are increased significantly. Given
the growing burden of breast cancer and observed de-
lays before medical consultation, an understanding of
the factors influencing patient delay is important to re-
duce late presentation of this curable cancer. The ob-
jectives of the current study were to evaluate the
frequency and length of delays in seeking medical
consultation, to assess the factors associated with them,
and to examine the relationship between patient delays
and disease stage.
METHODS
Study Population and Study Sites
Four hundred ninety-nine patients with newly diagnosed
breast cancer were enrolled from 2 main hospitals in
Karachi, Pakistan, AKUH and the Karachi Institute of
Radiation and Nuclear Medicine (KIRAN) cancer hospital.
KIRAN caters mostly to people from the low- or middle-
income group, whereas AKUH is a private hospital. These
patients were selected from a multicenter matched case-
control study consisting of 1,195 participants.17 All par-
ticipants were interviewed face to face by research medical
officers in clinics in a quiet and private place for to allow for
confidentiality and privacy. The questionnaire and interview
procedures were evaluated and revised after a pilot study
on 50 patients.
Ethical approval was obtained by the human research
ethics committee of the University of Adelaide and the
ethical review committees of the 2 hospitals in Karachi
Pakistan. Informed consent was obtained using the patient
information sheet and consent form. Participants were
informed clearly about the objectives and procedures of the
study, their rights and commitments, and the benefits and
risks involved. If the patients agreed to participate, they
were asked to sign the consent paper. The consent form of
the study was provided in both English and the local lan-
guage, Urdu. If a patient was unable to read the consent
form, the form was read out and verbal consent to par-
ticipate was obtained.
Variables in the Questionnaire
Patient delay was defined as the time between the ap-
pearances of any of the first symptoms of breast cancer and
the date of initial consultation for diagnostic mammogra-
phy, ultrasonography, or medical advice for breast symp-
toms. “No delay” (≤ 1 month) indicated that patients
sought medical advice for their breast cancer symptoms
CONTEXT
Key Objective
There is dearth of epidemiological studies to assess the extent of patient delay in breast cancer diagnosis among Pakistani
women. The main objective of the study was to evaluate the frequency, length of the patient delay and assess factors
associated with patient delay.
Knowledge Generated
Patient delay of 15.7 months is one of the longest delays and urgent measures are needed to improve the awareness of women
regarding breast cancer symptoms through comprehensive and positive breast cancer education campaigns, addressing
the myths and misconceptions.
Relevance
Information about the delayed presentation of breast cancer should call attention to the magnitude of the problem. Developing
strategies to shorten these delays would significantly reduce the impact of breast cancer on patients and the health care
system.
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TABLE 1. Sociodemographic and Clinical Characteristics of Patients With Breast Cancer in Two Hospitals in Karachi, Pakistan
Variable
No Delay
(n = 172)
Intermediate
Delay (< 3
months; n = 98)
Long Delay (‡ 3
months; n = 229) Total (n = 499)
P aNo. % No. % No. % No. %
Hospital , .001
AKUH 117 68.0 41 41.8 106 46.3 264 52.9
KIRAN 55 32.0 57 58.2 123 53.7 235 47.1
Age group, years .08
, 35 17 9.9 18 18.4 33 14.4 68 13.6
35-44 47 27.3 34 34.7 55 24.0 136 27.3
45-54 44 25.6 21 21.4 69 30.1 134 26.9
≥ 55 64 37.2 25 25.5 72 31.4 161 32.3
Education, grade , .001
, 8 50 29.1 43 44.3 111 48.7 204 41.0
8-12 59 34.3 33 34.0 74 32.5 166 33.4
. 12 63 36.6 21 21.6 43 18.9 127 25.6
Mother tongue .26
Urdu 83 48.3 44 44.9 110 48.0 237 47.5
Sindhi 22 12.8 14 14.3 33 14.4 69 13.8
Punjabi 23 13.4 9 9.2 21 9.2 53 10.6
Pashto 3 1.7 4 4.1 17 7.4 24 4.8
Balochi 6 3.5 3 3.1 11 4.8 20 4.0
Other 35 20.3 24 24.5 37 16.2 96 19.2
Marital status .76
Single 10 5.8 4 4.1 12 5.2 26 5.2
Married 130 75.6 81 82.7 180 78.6 391 78.4
Widow/divorcee 32 18.6 13 13.3 37 16.2 82 16.4
Socioeconomic status , .001
Upper 18 10.7 6 6.3 7 3.1 31 6.3
Middle 112 66.3 46 47.9 96 42.7 254 51.8
Lower 39 23.1 44 45.8 122 54.2 205 41.8
Parity .25
Nullipara 17 9.9 16 16.3 25 11.0 58 11.7
≤ 3 81 47.4 41 41.8 89 39.2 211 42.5
. 3 73 42.7 41 41.8 113 49.8 227 45.8
Menopausal status .47
Premenopause 79 46.5 50 51.5 99 44.2 228 46.4
Postmenopause 91 53.5 47 48.5 125 55.8 263 53.6
Benign breast disease .23
Yes 18 10.9 15 15.6 21 9.3 54 11.1
No 147 89.1 81 84.4 205 90.7 433 88.9
Family history of breast cancer .005
Yes 45 26.2 13 13.3 34 14.9 92 18.5
No 127 73.8 85 86.7 194 85.1 406 81.5
(Continued on following page)
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within a month of finding them. “Delay” indicated that
patients sought medical help . 1 month after noticing
possible symptoms of breast cancer. Delay was further
categorized into “intermediate delay” (, 3 months) and
“long delay” (≥ 3 months). Information was collected about
sociodemographic and reproductive factors including
age, level of education, socioeconomic status (SES), self-
reported family history of breast cancer or any other cancer,
and reasons for delay; anthropometric data were also
collected. The cutoffs used for bodymass index were based
on WHO and International Association for the Study of
Obesity criteria for the Asian population.18,19 Information
was also collected on breast tumor histopathology,
type, and grade, and the stage of disease was cate-
gorized according to TNM staging sourced from pathology
reports.20
The study participants were asked to recall the onset of any
symptoms that they became aware of and the day of first
medical consultation. Questions dealt with the presence of
the initial sign or symptom of breast cancer, any breast
lump, nipple discharge, breast pain, skin changes,
changes in breast shape, breast ulcer, arm edema, axillary
lymph nodes, or any other sign or symptom. The mode of
detection was recorded as either self-detected accidentally
or through regular BSE, by a clinician or health care pro-
vider, by a screening mammogram or other imaging test
indicating an abnormality, or on the basis of systemic
symptoms like weight loss or fatigue. To minimize recall
bias, the participants were reminded of events in the cal-
endar year, such as religious and national occasions,
school holidays, festival celebrations, or Independence
Day, to help them remember important dates relative to
their medical history.21
Reasons for delay included a lack of awareness about
breast cancer symptoms, use of traditional methods of
treatment, fear of breast cancer treatment, fear of di-
agnosis, fear of mastectomy, fear of rejection by husband,
possible shame and embarrassment, family commitments,
myths and misconceptions related to breast cancer, fi-
nancial constraints, and wrong assurances by health care
providers. Provider delay was defined as a delay in breast
cancer diagnosis by the health care provider when women
were reassured falsely without follow-up tests or proper
referrals, even though the women presented with typical
symptoms of breast cancer.
Statistical Analysis
Mean and standard deviations were obtained for contin-
uous variables, and categorical variables were assessed by
TABLE 1. Sociodemographic and Clinical Characteristics of Patients With Breast Cancer in Two Hospitals in Karachi, Pakistan (Continued)
Variable
No Delay
(n = 172)
Intermediate
Delay (< 3
months; n = 98)
Long Delay (‡ 3
months; n = 229) Total (n = 499)
P aNo. % No. % No. % No. %
Family history of cancer .03
Yes 70 40.7 25 25.5 73 32.0 168 33.7
No 102 59.3 73 74.5 155 68.0 330 66.3
BMI, kg/m2 .09
, 23 24 16.6 20 22.7 48 23.6 92 21.1
23-25 23 15.9 22 25.0 31 15.3 76 17.4
. 25 98 67.6 46 52.3 124 61.1 268 61.5
First symptom .04
Lump 150 87.2 86 89.6 216 94.3 452 90.9
Other 22 12.8 10 10.4 13 5.7 45 9.1
Mode of detection .05
Accidental 132 79.0 75 79.8 186 86.1 393 82.4
BSE 25 15.0 9 9.6 11 5.1 45 9.4
Clinical examination 5 3.0 6 6.4 12 5.6 23 4.8
Other 5 3.0 4 4.3 7 3.2 16 3.4
First consultation , .001
CAM 2 1.2 4 4.4 26 12.0 32 6.8
Medical health provider 160 98.8 87 95.6 190 88.0 437 93.2
Abbreviations: AKUH, Aga Khan University Hospital; BMI, body mass index; BSE, breast self-examination; CAM, complementary and alternative medicine;
KIRAN, Karachi Institute of Radiation and Nuclear Medicine.
aP values generated from χ2 test/Fisher’s exact test.
Shamsi et al
876 © 2020 by American Society of Clinical Oncology
Downloaded from ascopubs.org by 39.44.96.148 on July 19, 2020 from 039.044.096.148
Copyright © 2020 American Society of Clinical Oncology. See https://ascopubs.org/go/authors/open-access for reuse terms.
TABLE 2. Histopathologic Findings in Patients With Breast Cancer in Two Hospitals in Karachi, Pakistan (n = 514)
Variable
No Delay
Intermediate Delay
(< 3 months)
Long Delay
(‡ 3 months)
P aNo. % No. % No. %
Side with breast cancer .380
Right 86 50.9 45 46.9 109 48.4
Left 82 48.5 50 52.1 109 48.4
Both 1 0.6 1 1.0 7 3.1
Histopathology .440
IDC 139 80.8 85 86.7 187 81.7
Other 26 15.2 7 7.1 26 11.2
Grade .200
I 5 3.2 2 2.4 6 3.1
II 78 50.0 52 61.2 121 62.1
III 73 46.8 31 36.5 68 34.9
Tumor size, cm , .001
≤ 5 125 87.4 56 81.2 113 65.3
. 5 18 12.6 13 18.8 60 34.7
Nodes .160
NoN1 106 74.1 51 71.8 110 68.8
N2/N3 33 23.1 18 25.4 36 22.5
Nx 4 2.8 2 2.8 14 8.8
Metastasis .010
No 98 87.5 45 83.3 89 73.0
Yes 14 12.5 9 16.7 33 27.0
Stage of breast cancer .001
I 27 23.1 3 5.8 10 8.3
II 40 34.2 24 46.2 38 31.7
I 36 30.8 16 30.8 39 32.5
IV 14 12.0 9 17.3 33 27.5
Estrogen receptor .670
Positive 99 69.2 50 70.4 104 65.4
Negative 44 30.8 21 29.6 55 34.6
Progesterone receptor .750
Positive 82 58.2 45 63.4 95 60.5
Negative 59 41.8 26 36.6 62 39.5
HER2 neu status .640
Positive 26 20.6 9 14.1 25 17.4
Negative 85 67.5 43 67.2 97 67.4
Unknown 15 11.9 12 18.8 22 15.3
Type of tumor .900
Non-TNBC 111 82.8 53 80.3 118 81.4
TNBC 23 17.2 13 19.7 27 18.6
Abbreviations: HER2, human epidermal growth factor receptor 2; IDC invasive ductal carcinoma; TNBC, triple-negative breast cancer.
aP values generated from χ2 test/Fisher’s exact test.
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frequencies and percentages. To facilitate analysis, variables
withmultiple categories were collapsed to fewer categories in
a meaningful way. χ2 and Fisher’s exact tests were used to
assess categorical variables. To identify the most important
determinants of patient delay (no delay [, 1 month] v in-
termediate delay [, 3 months] v long delay [≥ 3 months]),
multinomial logistic regression was performed. The signifi-
cance levels for entering into and staying in the model were
both set to 0.25. Women with no delay (, 1 month) rep-
resented the reference group for both the intermediate and
the long patient delay groups. Univariate analysis of each
variable of interest and unadjusted odds ratio (ORs) and their
95% CI, together with P values, were calculated. In multi-
variate analyses, multinomial logistic regression was per-
formed to identify the factors associated with delay, while
adjusting for other variables. The overall significance of the
model was assessed by likelihood ratio test statistics.22
Statistical analysis of the data was carried out using the
SPSS package for Windows 22.0 (SPSS IBM, Armonk, NY).
RESULTS
Study Population
The sociodemographic characteristics of the study pop-
ulation (n = 499) in the 2 hospitals are listed in Table 1. The
mean (SD) age of patients was 48.0 (12.3) years. The mean
patient delay of 15.7 months is substantial but avoidable.
Out of the 65.5% of women who delayed seeing a doctor,
45.9% waited . 3 months before seeking professional
health care. A breast lump was the most common first
symptom of breast cancer (89.8% of women), with this
being an accidental finding in 82.1% of these women.
Routine BSE was performed by only 9.6% of women;
90.4% of women had not performed any BSE and neither
did they receive any clinical breast examinations during
routine visits to care providers or other clinics before ex-
periencing their breast symptoms. Only 3.5% of breast
cancer was detected by screening mammography, evi-
dence of the lack of available screening for the early de-
tection of breast cancer among Pakistani women.
Histopathologic findings of patients with breast cancer
stratified into 3 categories are listed in Table 2. Stage IV
cancer was highest (27%) among those who delayed
seeking medical advice for ≥ 3 months.
Table 3 lists the reasons for a delay .1 month in seeking
medical help in those women in whom symptoms were
noted that were consistent with a breast cancer diagnosis.
The most common cause for delay among these patients
was lack of awareness (55.2%), despite the fact that a lump
in the breast is the most common mode of breast cancer
presentation. Twenty-one women had a history of a breast
lump for .4 years and presented with ulcerated masses
because they had opted for traditional treatment.
Determinants of Patient Delay
Factors associated with patient delay among women by
univariate multinomial analysis are listed in Table 4. Uni-
variate analysis showed that KIRAN patients were more
likely to experience intermediate and longer delays than
were AKUH patients (OR, 2.96 [95% CI, 1.77 to 4.94] and
OR, 2.47 [95%CI, 1.63 to 3.73], respectively). A significant
association was observed between patient delay and ed-
ucation level (P , .001). Intermediate and longer delays
were both associated with an education level of less than
grade 8 (OR, 2.58 [95% CI, 1.36 to 4.90]) and (OR, 3.25
[95% CI, 1.95 to 5.43], respectively), compared with
women with an education level higher than grade 12. Both
delays were higher among women with an education level
of grade 8-12. Intermediate and longer delays were both
also associated with lower SES compared with higher SES
(OR, 3.39 [95% CI, 1.22 to 9.38] and OR, 8.04 [95% CI,
3.13 to 20.69], respectively). Patients were less likely to
delay their first consultation if they had a positive family
history of breast cancer (OR, 0.43 [95% CI, 0.22 to 0.85]).
There was a significant association between a delay of ≥
3months among women seeking traditional methods of
treatment such as homeopathic treatment and “hakeems”
for complementary and alternative medicine (CAM) com-
pared with those seeking help from health care providers
including gynecologists, surgeons, and general practi-
tioners (OR, 10.95 [95% CI, 2.56 to 46.83]).
A patient delay of ≥ 3 months was associated with a larger
tumor size of . 5 cm at the time of first presentation (OR,
3.69 [95% CI, 2.05 to 6.62]). A patient delay of ≥ 3 months
was associated with metastasis (OR, 2.60 [95% CI, 1.31 to
5.16]). Patient delays of, 3 months and ≥ 3 months were
also associated with advanced breast cancer stages II-IV
(Table 5).
The final multivariate model showed a strong association
between lower SES and a patient delay of ≥ 3 months (OR,
8.11 [95% CI, 2.46 to 26.69]; Table 6). Those patients who
delayed tended to present at a more advanced stage at
initial diagnosis. Compared with that of stage I, the OR for
stage IV was 4.83 (95% CI, 1.74 to 13.39) among women
who sought medical help for their symptoms after a delay of
≥ 3 months.
DISCUSSION
In this study, the finding that the majority of women had
become aware of a breast lump but still delayed any
TABLE 3. Reasons for Delay in Seeking Medical Help for Breast
Cancer Among Patients in TwoHospitals in Karachi, Pakistan (n = 339)
Reason for Delay No. % Mean (SD), months
Lack of awareness 187 55.2 11.4 (23.2)
Fears 46 13.6 12.3 (25.1)
Provider delay 32 9.4 8.5 (10.8)
Traditional methods of treatment 32 9.4 23.0 (39.4)
Other 42 12.4 10.7 (12.4)
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TABLE 4. Factors Associated With Patient Delay in Breast Cancer Diagnosis Among Women in Two Hospitals in Karachi, Pakistan
Variable
Intermediate Delay (< 3 months) Long delay (‡ 3 months)
Crude OR 95% CI P Crude OR 95% CI P
Hospital .001 .001
KIRAN 2.96 1.77 to 4.94 2.47 1.63 to 3.73
AKUH REFa REFa
Age group, years .02 .49
, 35 2.71 1.21 to 6.08 1.73 0.88 to 3.39
35-44 1.85 0.98 to 3.51 1.04 0.62 to 1.74
45-54 1.22 0.61 to 2.45 1.39 0.84 to 2.31
≥ 55 REFa REFa
Education, grade , .001 .05
, 8 2.58 1.36 to 4.90 3.25 1.95 to 5.43
8-12 1.68 0.87 to 3.22 1.84 1.10 to 3.08
. 12 REFa REFa
Mother tongue .16 .81
Urdu 0.77 0.41 to 1.46 1.25 0.73 to 2.16
Sindhi 0.93 0.40 to 2.17 1.42 0.70 to 2.89
Punjabi 0.57 0.23 to 1.45 0.86 0.41 to 1.83
Pashto 1.94 0.40 to 9.48 5.36 1.44 to 19.9
Balochi 0.73 0.17 to 3.20 1.73 0.58 to 5.19
Other REFa REFa
Marital status .18 .48
Single/widow/divorced 0.65 0.35 to 1.22 0.84 0.53 to 1.35
Married REFa REFa
Socioeconomic status .02 .03
Lower 3.39 1.22 to 9.38 8.04 3.13 to 20.69
Middle 1.23 0.46 to 3.30 2.20 0.88 to 5.50
Upper REFa REFa
Parity .20 .88
Nullipara 1.68 0.77 to 3.67 0.95 0.48 to 1.88
≤ 3 0.90 0.53 to 1.54 0.71 0.47 to 1.08
. 3 REFa REFa
Menopausal status .43 .65
Premenopause 1.23 0.74 to 2.02 0.91 0.61 to 1.36
Postmenopause REFa REFa
Family history of breast cancer .02 .01
Yes 0.43 0.22 to 0.85 0.50 0.30 to 0.81
No REFa REFa
Family history of cancer .01 .07
Yes 0.50 0.29 to 0.86 0.69 0.45 to 1.04
No REFa REFa
BMIb, kg/m2 .10 .08
, 23 1.78 0.89 to 3.54 1.58 0.91 to 2.76
23-25 2.04 1.03 to 4.03 1.07 0.58 to 1.94
. 25 REFa REFa
NOTE. Restricted to women who had ever had a full-term pregnancy (a pregnancy was considered full term if it resulted in a live birth or lasted
≥ 7 months).
Abbreviations: AKUH, Aga Khan University Hospital; BMI, body mass index; KIRAN, Karachi Institute of Radiation and Nuclear Medicine; OR,
odds ratio; REF, Reference.
aORs are for comparisons with those women who had no delay in seeking medical advice for their symptoms.
bBMI was categorized according to the WHO classification for Asians as underweight/normal weight (, 23 kg/m2), overweight (23-25 kg/m2),
or obese (≥ 26 kg/m2).
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medical consultation by a mean of 8.79 months is im-
portant. The main determinant of patient delay was lower
SES. Similar findings were observed in a study conducted in
Uganda in 2014 where patient delay was common (89%)
with a delay of more than 3months.23 A systematic review of
the factors associated with delay in Africa also showed low
SES as an important factor causing delay.24 Delay was also
strongly associated with advanced breast cancer stage, and
the ORs for stages II, III, and IV were higher compared with
that of stage I. These findings of a strong association be-
tween lower SES and advanced stage of breast cancer at
first consultation with patient delay are similar to the
findings of other studies.25-29
The most common reason given by patients for the delay in
diagnosis was a lack of awareness about the importance of
the finding of an abnormality in the breast (55.2%). Similar
findings were reported by a recent study in Pakistan despite
a smaller sample size of 200 patients.30 Similarly, there was
a strong influence of CAM, such as homeopathy and
“Hakeems,” in 2 other studies.31,32 Consulting a traditional
healer and low education were also reasons for patient
delay in a study among African women.27 Choosing
alternative medicine has been shown to be responsible for
delays in various other studies,23,31 but our study results
show it is less of an issue than in Malaysia, where it was
reported more often (42%)33 Other reasons for delay,
such as myths, fears related to diagnosis and treatment,
and family commitments, were also observed in other
studies.34-36 In a study of delayed breast cancer diagnosis in
Malaysia, CAM, negative information about breast cancer
and treatment such as the adverse effects of chemother-
apy, a perceived lack of a cure for breast cancer, and fear of
divorce or remarriage of the husband were the significant
factors leading to a delay in breast cancer diagnosis and
treatment.33
These findings confirm the results of other studies in de-
veloping countries and among minority groups in de-
veloped countries. All those studies have reported that
a lack of awareness and knowledge of breast cancer
symptoms and poor education are strongly associated with
patient delays.28,32,37-43 Moreover, as suggested by other
studies, more education and awareness are needed to
address misconceptions about breast cancer.34,44 It is
apparent that even in the more educated women, a lack of
awareness of the symptoms of breast cancer was also
a major reason for delay. An interesting finding was that
patients were more likely to delay their first consultation if
they did not have a family history of breast cancer. This
suggests that awareness of breast cancer significantly re-
duces delay because it is consistent with the personal
knowledge and experience of cancer in these families.
The limitations of this study include reliance on patient
recall of delay and symptoms, but this was minimized by
limiting the study to incident cases only and enrolling
patients within 6-12 months of breast cancer diagnosis.
Moreover, some verbal information was verified by medical
records and the documented findings of laboratory in-
vestigations. Delays were self- reported by patients, who in
some cases might have tended to underreport their delay
because of a wish to avoid any guilt. However, the major
strengths of our study were a large sample size of incident
cases only and comprehensive assessment and analysis of
a wide range of factors associated with patient delay. Good
quality of data collection was ensured by in-person in-
terviews conducted by medically qualified doctors. Their
medical history–taking experience ensured conduct of
interviews in a polite, sensitive and time-efficient manner
with patients’ confidence in them.
Delayed presentation of breast cancer is a preventable
problem, which if addressed, would have a significant
impact on reducing the morbidity and mortality of breast
cancer. First, it is recommended that women’s awareness
about breast cancer symptoms and the critical importance
of seeking immediate medical diagnosis and treatment be
improved. The implementation of an intensive, compre-
hensive, and positive breast cancer education campaign
through structured community health awareness programs
TABLE 5. Tumor Characteristics Associated With Patient Delay in Breast Cancer
Diagnosis in Two Hospitals in Karachi, Pakistan
Characteristic
Intermediate Delay
(< 3 months) Long Delay (‡ 3 months)
Crude
OR 95% CI P
Crude
OR 95% CI P
Grade .69 .67
I 0.94 0.17 to 5.12 1.29 0.38 to 4.42
II 1.57 0.91 to 2.71 1.67 1.08 to 2.58
III REFa REFa
Tumor size, cm .23 , .001
. 5 1.61 0.74 to 3.52 3.69 2.05 to 6.62
≤ 5 REFa REFa
Nodes .71 .86
NoN1 0.88 0.45 to 1.71 0.95 0.55 to 1.63
N2/N3 REFa REFa
Metastasis .47 .007
Metastasis 1.4 0.56 to 3.47 2.60 1.31 to 5.16
No metastasis REF REFa
Stage .02 , .001
IV 5.79 1.35 to 24.85 6.36 2.44 to 16.58
III 4.00 1.06 to 15.13 2.93 1.24 to 6.88
II 5.40 1.48 to 19.73 2.57 1.1 to 6.01
I REFa REFa
Abbreviations: OR odds ratio; REF, Reference.
aORs are for comparisons with those women who had no delay in seeking
medical advice for their symptoms.
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addressing the myths and misconceptions related to breast
cancer will reduce the burden of late-stage breast cancer in
Pakistani women. Such an education campaign will need to
be cognizant of the sociocultural and religious values of
Pakistani society, while making women “breast aware” of
their healthy breasts and any changes in them. The second
recommendation is to include health care providers, cli-
nicians, nurses, and female health visitors in such edu-
cational campaigns. It is essential that health care providers
and traditional healers play their roles in timely referrals and
necessary investigations. The resource requirements to
implement such a program are relatively limited and do not
require expensive technology; however, this program will
have a significant impact on reducing the life-threatening
delay in breast cancer diagnosis. The third action to
minimize such a delay is to provide low-cost mammograms,
with a target population of women with a high-risk profile in
particular. Last but not least, in Pakistan, as in any other
LMIC, health care access and treatment facilities for pa-
tients with breast cancer should be improved as a part of
a breast cancer control program. For timely initiation of
breast cancer treatment and quality care, awareness and
education to avoid delays will not be useful without available
cancer hospitals. Delayed presentation of breast cancer is
a preventable problem that, if addressed, would have
a significant impact on reducing the morbidity andmortality
of the disease.
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